Chevy Chase Trust
AYLA

Chevy Chase Trust’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

Chevy Chase Trust’s Portfolio AYLA Stock Details AYLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,000
Closed -$170K – 691
2021
Q3 		$170K Hold
15,000
– – ﹤0.01% 656
2021
Q2 		$153K Hold
15,000
– – ﹤0.01% 671
2021
Q1 		$164K Buy
+15,000
New +$214K ﹤0.01% 670

Other funds holding AYLA

Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
DAM
DLD Asset Management New York $1.51B AUM 5.32% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Bridgeway Capital Management
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Boothbay Fund Management
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Chevy Chase Trust's AYLA Position: Q4 2021 in Review

Chevy Chase Trust sold out of Ayala Pharmaceuticals, Inc. Common Stock (AYLA) in Q4 2021, closing a stake of 15,000 shares — an estimated $170K sold.

Chevy Chase Trust first reported a position in AYLA in Q1 2021 and held it in 3 quarters. The position peaked at $170K in Q3 2021. 13 funds tracked by Wall St. Rank hold AYLA as of Q4 2021.

  • Chevy Chase Trust reported no remaining Ayala Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Chevy Chase Trust sold 15,000 Ayala Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $170K.
  • Chevy Chase Trust first reported a position in Ayala Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Chevy Chase Trust's Ayala Pharmaceuticals, Inc. Common Stock position peaked at $170K in Q3 2021.
  • 13 funds tracked by Wall St. Rank held Ayala Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on Chevy Chase Trust's 13F filing for Q4 2021, filed 31 Jan 2022.